Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-18

Clinical Trial Update: Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy and safety of dietary supplementation with diamine oxidase to improve symptoms in patients with irritable bo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • diamine oxidase dietary supplement (diamine oxidase)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Irritable Bowel Syndrome (IBS) | Phase 4 | Status: UNKNOWN